UBIVAC LLC has a total of 11 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AROG PHARMACEUTICALS INC, TEZAPSIDIS NIKOLAOS and DEL MAR PHARMACEUTICALS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | Hong Kong | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Hu Hong-Ming | 11 |
#2 | Twitty Christopher | 10 |
#3 | Dubay Christopher | 5 |
#4 | Moudgil Tarsem | 5 |
#5 | Yu Guangjie | 5 |
#6 | Fox Bernard | 5 |
#7 | Hilton Traci | 5 |
#8 | Paustian Christopher | 5 |
#9 | Leshane Erik | 5 |
#10 | Van De Ven Rieneke | 5 |
Publication | Filing date | Title |
---|---|---|
CN105934442A | Ubiquitinylated proteins | |
US2014112977A1 | Allogeneic autophagosome-enriched composition for the treatment of disease |